Physician CME

In this 1-hour presentation, Dr. Charles Vega discusses the science behind multicancer early detection (MCED) testing and explores the benefits and limitations of MCED tests available for clinical use and undergoing investigation in clinical trials. Faculty also share practical clinical information on integrating MCED testing in current workflows, including identifying patients who are appropriate candidates for MCED testing, addressing patient concerns, and interpreting results. A guide to discussing MCED testing with patients is also provided.

This Community Practice Connections™ program provides an in-depth review of some of the key highlights from the meeting series on clinical challenges and new opportunities in managing myelodysplastic syndromes (MDS) that was held with the Association of Community Cancer Centers. This unique and engaging multimedia activity is ideal for the community-based clinician and focuses on the practical aspects of managing patients with lower- and higher-risk MDS. The program is designed for those who did not attend the live meetings and to help reinforce learnings for those who did.

A growing body of evidence has demonstrated the correlation between fluctuations in retinal fluid and worse anatomical and visual outcomes in patients with neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME) treated with intravitreal anti-vascular endothelial growth factor therapies. Appropriate selection of treatment and dosing regimens that prioritize stability of retinal anatomy while minimizing fluctuations in central retina thickness are essential for achieving optimal outcomes.

Therapies that offer longer duration of action have the potential to stabilize the retinal anatomy and minimize fluctuations in retinal fluid. In this CE activity, experts in the field will review how fluctuations in retinal fluid may negatively impact anatomical and functional outcomes in patients with nAMD and DME, as well as evaluate the latest clinical and real-world evidence for therapies that can improve retina fluid control and lessen fluctuations in central subretinal thickness. The presentation of challenging, real-world cases also allows for the application of this valuable content into clinical practice.